Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness of CadAI-B for Breast

NCT: NCT06352684 · COMPLETED

NCT IDNCT06352684
StatusCOMPLETED
Start Date2023-11-24
Completion2025-08-21
SponsorBeamWorks Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the effectiveness of lesion detection and diagnosis-aiding software (CadAI-B for Breast) during ultrasound (US) examination

Frequently Asked Questions

What is Effectiveness of CadAI-B for Breast?

Effectiveness of CadAI-B for Breast is a clinical trial registered under NCT06352684. Current status: COMPLETED.

What is the status of NCT06352684?

The current status of NCT06352684 (Effectiveness of CadAI-B for Breast) is: COMPLETED.

When did Effectiveness of CadAI-B for Breast start?

Effectiveness of CadAI-B for Breast started on 2023-11-24.

Related Devices

K260086CadAI-B DxBeamWorks, Inc. PMA P250008OCT imaging system with AI/ML software for adjunctive detection of breast cancerPerimeter Medical Imaging Ai, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑